Henry Schein (NASDAQ:HSIC) Issues Earnings Results

Henry Schein (NASDAQ:HSICGet Rating) released its quarterly earnings data on Tuesday. The company reported $1.30 EPS for the quarter, topping the Zacks’ consensus estimate of $1.19 by $0.11, RTT News reports. Henry Schein had a net margin of 5.09% and a return on equity of 15.84%. The firm had revenue of $3.18 billion during the quarter, compared to analysts’ expectations of $3.12 billion. During the same period in the previous year, the business posted $1.24 earnings per share. The company’s revenue for the quarter was up 8.7% compared to the same quarter last year.

HSIC opened at $80.45 on Tuesday. Henry Schein has a 1-year low of $70.25 and a 1-year high of $92.68. The company has a current ratio of 1.67, a quick ratio of 0.86 and a debt-to-equity ratio of 0.20. The company has a market cap of $11.11 billion, a P/E ratio of 18.04, a price-to-earnings-growth ratio of 1.41 and a beta of 0.75. The company has a fifty day moving average price of $87.29 and a two-hundred day moving average price of $80.39.

HSIC has been the topic of a number of research analyst reports. StockNews.com assumed coverage on shares of Henry Schein in a research note on Thursday, March 31st. They issued a “buy” rating on the stock. Morgan Stanley raised their price target on shares of Henry Schein from $67.00 to $72.00 and gave the company an “underweight” rating in a research note on Wednesday, February 16th. Zacks Investment Research downgraded shares of Henry Schein from a “buy” rating to a “hold” rating and set a $95.00 target price for the company. in a research note on Tuesday, April 19th. Barrington Research lifted their target price on shares of Henry Schein from $96.00 to $102.00 in a research note on Wednesday, February 16th. Finally, Robert W. Baird lifted their target price on shares of Henry Schein from $98.00 to $103.00 in a research note on Wednesday, February 16th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $94.50.

In other Henry Schein news, Director Scott Philip Serota acquired 1,000 shares of Henry Schein stock in a transaction dated Friday, March 4th. The stock was purchased at an average cost of $85.87 per share, for a total transaction of $85,870.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Mark E. Mlotek sold 24,075 shares of Henry Schein stock in a transaction dated Thursday, February 24th. The shares were sold at an average price of $82.99, for a total transaction of $1,997,984.25. The disclosure for this sale can be found here. Insiders own 1.00% of the company’s stock.

Institutional investors have recently added to or reduced their stakes in the stock. Barclays PLC raised its holdings in shares of Henry Schein by 14.4% in the 4th quarter. Barclays PLC now owns 249,861 shares of the company’s stock worth $19,374,000 after purchasing an additional 31,403 shares during the period. LPL Financial LLC increased its position in Henry Schein by 9.6% in the fourth quarter. LPL Financial LLC now owns 19,334 shares of the company’s stock worth $1,502,000 after buying an additional 1,701 shares during the last quarter. MML Investors Services LLC increased its position in Henry Schein by 4.9% in the fourth quarter. MML Investors Services LLC now owns 8,405 shares of the company’s stock worth $652,000 after buying an additional 391 shares during the last quarter. HB Wealth Management LLC bought a new position in shares of Henry Schein in the fourth quarter worth $225,000. Finally, Metropolitan Life Insurance Co NY boosted its holdings in shares of Henry Schein by 16.1% in the fourth quarter. Metropolitan Life Insurance Co NY now owns 15,850 shares of the company’s stock worth $1,229,000 after acquiring an additional 2,200 shares during the period. Institutional investors and hedge funds own 94.30% of the company’s stock.

About Henry Schein (Get Rating)

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Recommended Stories

Earnings History for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.